Your shopping cart is currently empty

PRMT5-IN-41 (compound 130) is an effective orally active inhibitor of PRMT5. It inhibits the hERG ion channel with an IC50 of 1.36 µM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 25 mg | $2,870 | 3-6 months | 3-6 months | |
| 50 mg | $3,780 | 3-6 months | 3-6 months | |
| 100 mg | $5,200 | 3-6 months | 3-6 months |
| Description | PRMT5-IN-41 (compound 130) is an effective orally active inhibitor of PRMT5. It inhibits the hERG ion channel with an IC50 of 1.36 µM. |
| In vitro | PRMT5-IN-41 (compound 130) (0-10000 nM) demonstrates antiproliferative activity, with IC50 values of 5.8 µM and 1291.6 µM against HCT116 MTAP(-/-) and HCT116 WT cells, respectively. |
| In vivo | The bioavailability of PRMT5-IN-41 in ICR mice is observed to be 77.5% by oral administration, with half-lives of 4.5 hours for intravenous injection and 3.34 hours for oral consumption when administered at doses of 3 mg/kg (i.v.) and 10 mg/kg (p.o.), respectively. |
| Molecular Weight | 477.39 |
| Formula | C22H16F5N5O2 |
| Cas No. | 3034034-32-4 |
| Smiles | C(N(C)[C@H]1C=2C(OC1)=CC(C(C(F)(F)F)(F)F)=CC2)(=O)C=3C=C4N5C(C(N)=NC4=CC3)=CN=C5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.